189 related articles for article (PubMed ID: 15093697)
1. Central stresscopin modulates cardiovascular function through the adrenal medulla in conscious rats.
Chu CP; Qiu DL; Kato K; Kunitake T; Watanabe S; Yu NS; Nakazato M; Kannan H
Regul Pept; 2004 Jun; 119(1-2):53-9. PubMed ID: 15093697
[TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricular injection of stresscopin-related peptide enhances cardiovascular function in conscious rats.
Jin R; Li MZ; Bing YH; Piao RL; Li YJ; Jin QH; Qiu DL; Kannan H; Chu CP
Regul Pept; 2013 Sep; 186():7-11. PubMed ID: 23850799
[TBL] [Abstract][Full Text] [Related]
3. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
[TBL] [Abstract][Full Text] [Related]
4. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
[TBL] [Abstract][Full Text] [Related]
5. Role of brain adrenoceptors in the corticortopin-releasing factor-induced central activation of sympatho-adrenomedullary outflow in rats.
Yorimitsu M; Okada S; Yamaguchi-Shima N; Shimizu T; Arai J; Yokotani K
Life Sci; 2008 Feb; 82(9-10):487-94. PubMed ID: 18201726
[TBL] [Abstract][Full Text] [Related]
6. Satiety induced by central stresscopin is mediated by corticotrophin-releasing factor receptors and hypothalamic changes in chicks.
Cline MA; Prall BC; Rogers JO; Tachibana T
Pharmacol Biochem Behav; 2009 Jun; 92(4):663-9. PubMed ID: 19324068
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular actions of central neuropeptide W in conscious rats.
Yu N; Chu C; Kunitake T; Kato K; Nakazato M; Kannan H
Regul Pept; 2007 Feb; 138(2-3):82-6. PubMed ID: 17011641
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear.
Stiedl O; Meyer M; Jahn O; Ogren SO; Spiess J
J Pharmacol Exp Ther; 2005 Mar; 312(3):905-16. PubMed ID: 15537825
[TBL] [Abstract][Full Text] [Related]
9. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor.
Hsu SY; Hsueh AJ
Nat Med; 2001 May; 7(5):605-11. PubMed ID: 11329063
[TBL] [Abstract][Full Text] [Related]
10. Microinjection of urocortin into the rat nucleus tractus solitarii decreases arterial blood pressure.
Yamazaki T; Waki H; Kohsaka A; Nakamura T; Cui H; Yukawa K; Maeda M
Auton Neurosci; 2008 Nov; 142(1-2):51-4. PubMed ID: 18804421
[TBL] [Abstract][Full Text] [Related]
11. Urocortins as cardiovascular peptides.
Takahashi K; Totsune K; Murakami O; Shibahara S
Peptides; 2004 Oct; 25(10):1723-31. PubMed ID: 15476939
[TBL] [Abstract][Full Text] [Related]
12. Sympatho-adrenal medullary functions in response to intracerebroventricularly injected corticotropin-releasing factor in anesthetized rats.
Kurosawa M; Sato A; Swenson RS; Takahashi Y
Brain Res; 1986 Mar; 367(1-2):250-7. PubMed ID: 3486023
[TBL] [Abstract][Full Text] [Related]
13. Ancient evolution of stress-regulating peptides in vertebrates.
Chang CL; Hsu SY
Peptides; 2004 Oct; 25(10):1681-8. PubMed ID: 15476935
[TBL] [Abstract][Full Text] [Related]
14. Influence of urocortin and corticotropin releasing factor on venous tone in conscious rats.
Abdelrahman AM; Lin Lim S; Pang CC
Eur J Pharmacol; 2005 Mar; 510(1-2):107-11. PubMed ID: 15740730
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular actions of the stress-related neurohormonal peptides, corticotropin-releasing factor and urotensin-I in the trout Oncorhynchus mykiss.
Le Mével JC; Mimassi N; Lancien F; Mabin D; Conlon JM
Gen Comp Endocrinol; 2006 Mar; 146(1):56-61. PubMed ID: 16386738
[TBL] [Abstract][Full Text] [Related]
16. Adrenal adrenaline- and noradrenaline-containing cells and celiac sympathetic ganglia are differentially controlled by centrally administered corticotropin-releasing factor and arginine-vasopressin in rats.
Yamaguchi-Shima N; Okada S; Shimizu T; Usui D; Nakamura K; Lu L; Yokotani K
Eur J Pharmacol; 2007 Jun; 564(1-3):94-102. PubMed ID: 17350615
[TBL] [Abstract][Full Text] [Related]
17. Urocortins and the regulation of gastrointestinal motor function and visceral pain.
Martinez V; Wang L; Million M; Rivier J; Taché Y
Peptides; 2004 Oct; 25(10):1733-44. PubMed ID: 15476940
[TBL] [Abstract][Full Text] [Related]
18. Expression of urocortin 3/stresscopin in human adrenal glands and adrenal tumors.
Takahashi K; Totsune K; Saruta M; Fukuda T; Suzuki T; Hirose T; Imai Y; Sasano H; Murakami O
Peptides; 2006 Jan; 27(1):178-82. PubMed ID: 16095756
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing factor: effects on the autonomic nervous system and visceral systems.
Brown MR; Fisher LA
Fed Proc; 1985 Jan; 44(1 Pt 2):243-8. PubMed ID: 2981744
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of long-term central and peripheral administration of urocortin, corticotropin-releasing factor, and adrenocorticotropin in sheep.
Weisinger RS; Blair-West JR; Burns P; Denton DA; Purcell B; Vale W; Rivier J; Weisinger HS; May CN
Endocrinology; 2004 Dec; 145(12):5598-604. PubMed ID: 15319360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
